Isolation of Daudi Cells with Reduced Sensitivity to Interferon.

References

1. Adams A., Strander H., Cantell K. 1975; Sensitivity of the Epstein-Barr virus-transformed human lymphoid cell lines to interferon. Journal of General Virology 28:207–217
   [Google Scholar]
2. Affabris Emma C., Rossi G. B. 1982; Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain. Virology 120:441–452
   [Google Scholar]
3. Aguet M. 1980; High-affinity binding of¹²⁵I-labelled mouse interferon to a specific cell surface receptor. Nature, London 284:459–61
   [Google Scholar]
4. Aguet M., Blanchard B. 1981; High-affinity binding of ¹²⁵I-labeled mouse interferon to a specific cell surface receptor. II. Analysis of binding properties. Virology 115:249–261
   [Google Scholar]
5. Arce-Gomez B., Jones E. A., Barnstable C. J., Solomon E., BodmerK W. 1978; The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for β₂ microglobulin. Tissue Antigens 11:96–112
   [Google Scholar]
6. Bertino J. R., Srimatkandada S., Engel D., Medina W. D., Scheer D. I., Moroson B. A., Dube S. 1982; Gene amplification in a methotrexate-resistant human leukemia line K-562. In Gene Amplification pp 23–27 Edited by Schimke R. T. New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
7. Borecky L., Fuchsberger N., Najnicka-Gondova V., Clampor R., Altaner C. 1977; The Cell-growth inhibitory effect of interferon. Studies of a resistant cell-subline. Neoplasma 24:125–137
   [Google Scholar]
8. Bostock C. J., Tyler-Smith C. 1982; Amplification of dihydrofolate reductase genes and other DNA sequences in mouse cells. In Gene Amplification pp 15–21 Edited by Schimke R. T. New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
9. Brown P. C., Kaufman R. J., Haber D., Kchimke R. T. 1982; Characteristics of dihydrofolate reductase gene amplification in murine and Chinese hamster ovary cell lines. In Gene Amplification pp 9–13 Edited by Schimke R. T. New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
10. Chany C., Vignal M. 1970; Effect of prolonged interferon treatment on mouse embryonic fibroblasts transformed by murine sarcoma virus. Journal of General Virology 7:203–210
    [Google Scholar]
11. Chen H. Y., Sato T., Fuse A., Kuwata T., Content J. 1981; Resistance to interferon of human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action. Journal of General Virology 52:177–181
    [Google Scholar]
12. Cooper J. E. K. 1973; 5-A single cell clones. In Tissue Culture Methods and Application pp 266–269 Edited by Kruse P. F. Jr, Patterson M. K. Jr New York & London: Academic Press;
    [Google Scholar]
13. Gresser I., Bandu M.-T., Brouty-Boye D. 1974; Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin. Journal of the National Cancer Institute 52:553–559
    [Google Scholar]
14. Hilfenhaus J. 1976; Propagation of Semliki Forest virus in various human lymphoblastoid cell lines. Journal of General Virology 33:539–542
    [Google Scholar]
15. Klein E., Klein G., Nadkarni J. S., Nadkarni J. J., Wigzell H., Clifford P. 1968; Surface IgM kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Research 28:1300–1310
    [Google Scholar]
16. Kuwata T., Fuse A., Morinaga N. 1976; Effect of interferon upon cell and virus growth in transformed human cell lines. Journal of General Virology 33:7–15
    [Google Scholar]
17. Masters J., Keeley B., Gay H., Attardi G. 1982; Variable content of double minute chromosomes is not correlated with degree of phenotype instability in methotrexate-resistant human cell lines. Molecular and Cellular Biology 2:498–507
    [Google Scholar]
18. Mogensen K. E., Bandu M.-T., Vignaux F., Aguet M., Kresser I. 1981; Binding of ¹²⁵I-labelled human α-interferon to human lymphoid cells. International Journal of Cancer 28:575–582
    [Google Scholar]
19. Mogensen K. E., Cantell K. 1977; Production and preparation of human leukocyte interferon. Pharmacology and Therapeutics C 1:369–381
    [Google Scholar]
20. Mogensen K. E., Cantell K. 1979; Non-specific adsorption of interferon to immobilized serum immune-globulin. Journal of General Virology 45:171–175
    [Google Scholar]
21. Rosa F., Fellous M., Dron M., Tovey M. G., Revel M. 1982; Presence of an abnormal β₂-microglobulin mRNA in Daudi cells: induction by interferon. Immunogenetics 17:125–131
    [Google Scholar]
22. Silverman R. H., Watling D., Balkwill F. R., Trowsdale J., Kerr I. M. 1982; The ppp(A2′p)_nA and protein kinase systems in wild-type and interferon-resistant Daudi cells. European Journal of Biochemistry 126:333–341
    [Google Scholar]
23. Tomita Y., Cantell K., Kuwata T. 1982; Effects of human ** interferon on cell growth, replication of virus and induction of 2′–5′ oligoadenylate synthetase in three human lymphoblastoid cell lines and K562 cells. International Journal of Cancer 30:161–165
    [Google Scholar]
24. Tovey M. G., Dron M., Gresser I. 1982; Interferon enhances the expression of Epstein-Barr virus early antigen in Daudi cells. Journal of General Virology 60:31–38
    [Google Scholar]
25. Tovey M. G., Dron M., Mogensen K. E., Lebleu B., Mechti N., Begon-Lours-Guymarho J. 1983; Isolation of Daudi cells with reduced sensitivity to interferon. II. On the mechanisms of resistance. Journal of General Virology 64:2649–2653
    [Google Scholar]
26. Verhaegen-Lewalle M., Kuwata T., Zhang Z.-X., Declercq E., Cantell K., Content J. 1982; 2-5A synthetase activity induced by interferon α, β and γ in human cell lines differing in their sensitivity to the anticellular and antiviral activities of these interferons. Virology 117:425–434
    [Google Scholar]
27. Weissenbach J., Zeevi M., Landau T., Revel M. 1979; Identification of the translation products of human fibroblast interferon mRNA in reticulocyte lysates. European Journal of Biochemistry 98:7–8
    [Google Scholar]